9 Facts About Why Menopause Significantly Raises Your Kidney Stone Risk
Nobody warned me that menopause could affect my kidneys. When a friend landed in the ER with her first kidney stone at 54, her doctor told her it was 'just bad luck.' It wasn't — her estrogen had dropped off a cliff two years earlier. This is one of those connections that women deserve to know about before the pain hits.
Learn more about Rose →Estrogen Actively Protects Against Calcium Oxalate Stones — Until It Doesn't
Estrogen has a direct inhibitory effect on oxalate absorption in the gut and promotes the renal excretion of oxalate in a way that keeps urinary oxalate concentrations lower. When estrogen levels fall during perimenopause and menopause, this protective brake is lifted, allowing oxalate to accumulate more readily in the urine. Calcium oxalate stones are the most common type of kidney stone, accounting for roughly 80% of cases, so this mechanism matters enormously.
Urinary Citrate Drops Significantly After Menopause
Citrate is the kidney's natural stone-fighting molecule — it binds to calcium in the urine and prevents it from crystallising into stones. Estrogen stimulates citrate excretion, so as estrogen declines, urinary citrate levels fall measurably. Studies comparing premenopausal and postmenopausal women show that postmenopausal women consistently excrete less citrate, a condition called hypocitraturia, which is one of the strongest known risk factors for kidney stone formation.
Bone Loss and Kidney Stones Are Connected Through the Same Mechanism
When estrogen falls, bone resorption accelerates — the skeleton releases more calcium into the bloodstream than the body can efficiently use or excrete. This excess circulating calcium spills into the urine, raising urinary calcium concentrations in a process called hypercalciuria. High urinary calcium dramatically increases the likelihood that calcium will bind to oxalate or phosphate and crystallise into a stone.
Urinary pH Shifts Toward Acidity After Menopause
Estrogen helps maintain a slightly alkaline urinary environment, and its loss tends to push urinary pH in a more acidic direction. A lower urinary pH does not favour calcium oxalate stones directly, but it strongly promotes uric acid stone formation — a type of stone that becomes more common in postmenopausal women. This pH shift is an underappreciated second pathway through which menopause increases overall stone risk.
Parathyroid Hormone Activity Increases as Estrogen Falls
Estrogen normally helps suppress parathyroid hormone (PTH), which regulates calcium balance. When estrogen declines, PTH activity can rise in a compensatory effort to manage falling calcium absorption, and elevated PTH signals the kidneys to reabsorb less calcium — meaning more calcium ends up in the urine. This hormonal cascade creates a direct biochemical chain from estrogen loss to hypercalciuria to increased stone risk.
Dehydration Risk Increases During Menopause — And Concentration Matters
Hot flushes cause significant fluid loss through sweating, and many women in menopause find themselves chronically mildly dehydrated without fully realising it. Urine that is consistently concentrated gives calcium, oxalate, and uric acid less room to stay dissolved, pushing the chemistry toward crystallisation. Even a modest, consistent increase in daily fluid intake has been shown in large prospective studies to substantially reduce kidney stone incidence.
Hormone Therapy Appears to Reduce Stone Risk — But the Picture Is Nuanced
Several observational studies have found that women taking estrogen-containing hormone therapy have lower rates of kidney stones than those who do not, which is consistent with estrogen's known protective roles in citrate excretion and calcium handling. However, the Women's Health Initiative trial noted a modest increase in kidney stones among women taking combined oral estrogen-progestogen therapy, possibly related to the oral route increasing certain clotting and calcium-related markers. Transdermal estrogen, which avoids first-pass liver metabolism, may carry a different risk profile, and this remains an active area of research.
Dietary Calcium Restriction Is the Wrong Response — And Can Make Things Worse
A common instinct when told about calcium and kidney stones is to cut back on dietary calcium, but this is physiologically counterproductive. Dietary calcium consumed with meals binds to oxalate in the gut, preventing its absorption into the bloodstream and subsequent excretion in the urine. Restricting dietary calcium actually increases urinary oxalate, which raises stone risk — a finding confirmed in large randomised trials. Postmenopausal women already face pressure to maintain bone density, making adequate dietary calcium doubly important.
A Prior Stone History Compounds Menopausal Risk Significantly
Women who had a kidney stone before menopause are at substantially higher recurrence risk once estrogen declines, because the hormonal protection that may have partially suppressed their underlying stone-forming tendency is now removed. Research suggests recurrence rates in stone formers can exceed 50% within five years without active dietary and metabolic management. For women with a prior stone history, menopause is a sensible trigger point to revisit metabolic stone evaluation — including a 24-hour urine collection to assess exactly what the kidneys are excreting.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.